Seres Therapeutics
MCRB
#8982
Rank
$95.89 M
Marketcap
$0.55
Share price
-3.91%
Change (1 day)
-24.66%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -$0.14 Billion USD

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$97.73 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -$0.14 Billion34.63%
2023 -$97.73 Million-59.97%
2022 -$0.25 Billion289.57%
2021 -$62.67 Million-27.3%
2020 -$86.21 Million23%
2019 -$70.09 Million-30.11%
2018 -$0.11 Billion9.73%
2017 -$91.4 Million-0.74%
2016 -$92.08 Million70.96%
2015 -$53.86 Million257.11%
2014 -$15.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.25 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.26 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.43 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA